AvevoRx Signs Agreement for Subcutaneous Immunoglobulin Drug CUVITRU ®

Deal announced amidst continuous, rapid growth and expansion for AvevoRx GREENSBORO, N.C., Sept. 14, 2023 /PRNewswire-PRWeb/ -- AvevoRx, a national, independent provider of specialty infusion pharmacy services, has signed an agreement with Cambridge, Mass.-based Takeda (TSE:4502/NYSE:...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: LIC Source Type: news
More News: Pharmaceuticals